Patents by Inventor Svein Mjaaland

Svein Mjaaland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EGFR TARGETED THERAPY OF NEUROLOGICAL DISORDERS AND PAIN
    Publication number: 20230016235
    Abstract: The present invention relates to compositions and methods for treatment of neurological disorders. In particular, the present invention relates to the epidermal growth factor receptor (EGFR) as a clinical target for treatment of neurological disorders, preferably in conjunction with neuropathic pain.
    Type: Application
    Filed: July 15, 2022
    Publication date: January 19, 2023
    Inventors: Christian Kersten, Marte Cameron, Svein Mjåland
  • EGFR targeted therapy of neurological disorders and pain
    Patent number: 11396548
    Abstract: The present invention relates to compositions and methods for treatment of neurological disorders. In particular, the present invention relates to the epidermal growth factor receptor (EGFR) as a clinical target for treatment of neurological disorders, preferably in conjunction with neuropathic pain. The invention relates in more detail to compositions comprising inhibitors of EGFR.
    Type: Grant
    Filed: March 19, 2020
    Date of Patent: July 26, 2022
    Assignee: Sykehuset Sørlandet HF
    Inventors: Christian Kersten, Marte Grønlie Cameron, Svein Mjåland
  • EGFR TARGETED THERAPY
    Publication number: 20210236635
    Abstract: The present invention relates to compositions and methods for treatment of neurological disorders. In particular, the present invention relates to EGFR as a clinical target for treatment of neurological disorders.
    Type: Application
    Filed: April 19, 2021
    Publication date: August 5, 2021
    Inventors: Christian Kersten, Marte Grønlie Cameron, Svein Mjåland
  • EGFR targeted therapy
    Patent number: 10980879
    Abstract: The present invention relates to compositions and methods for treatment of neurological disorders. In particular, the present invention relates to EGFR as a clinical target for treatment of neurological disorders.
    Type: Grant
    Filed: July 5, 2012
    Date of Patent: April 20, 2021
    Assignee: SYKEHUSET SØRLANDET HF
    Inventors: Christian Kersten, Marte Grønlie Cameron, Svein Mjåland
  • EGFR TARGETED THERAPY OF NEUROLOGICAL DISORDERS AND PAIN
    Publication number: 20200216547
    Abstract: The present invention relates to compositions and methods for treatment of neurological disorders. In particular, the present invention relates to the epidermal growth factor receptor (EGFR) as a clinical target for treatment of neurological disorders, preferably in conjunction with neuropathic pain.
    Type: Application
    Filed: March 19, 2020
    Publication date: July 9, 2020
    Inventors: Christian Kersten, Marte Grønlie Cameron, Svein Mjåland
  • EGFR targeted therapy of neurological disorders and pain
    Patent number: 10611844
    Abstract: The present invention relates to compositions and methods for treatment of neurological disorders. In particular, the present invention relates to the epidermal growth factor receptor (EGFR) as a clinical target for treatment of neurological disorders, preferably in conjunction with neuropathic pain. The invention relates in more detail to compositions comprising inhibitors of EGFR.
    Type: Grant
    Filed: September 20, 2016
    Date of Patent: April 7, 2020
    Assignee: Sykehuset Sørlandet HF
    Inventors: Christian Kersten, Marte Grønlie Cameron, Svein Mjåland
  • EGFR TARGETED THERAPY OF NEUROLOGICAL DISORDERS AND PAIN
    Publication number: 20170073419
    Abstract: The present invention relates to compositions and methods for treatment of neurological disorders. In particular, the present invention relates to the epidermal growth factor receptor (EGFR) as a clinical target for treatment of neurological disorders, preferably in conjunction with neuropathic pain.
    Type: Application
    Filed: September 20, 2016
    Publication date: March 16, 2017
    Inventors: Christian Kersten, Marte Grønlie Cameron, Svein Mjåland
  • EGFR TARGETED THERAPY OF NEUROLOGICAL DISORDERS AND PAIN
    Publication number: 20150320861
    Abstract: The present invention relates to compositions and methods for treatment of neurological disorders. In particular, the present invention relates to the epidermal growth factor receptor (EGFR) as a clinical target for treatment of neurological disorders, preferably in conjunction with neuropathic pain.
    Type: Application
    Filed: December 20, 2013
    Publication date: November 12, 2015
    Inventors: Christian Kersten, Marte Grønlie Cameron, Svein Mjåland
  • EGFR TARGETED THERAPY
    Publication number: 20140134161
    Abstract: The present invention relates to compositions and methods for treatment of neurological disorders. In particular, the present invention relates to EGFR as a clinical target for treatment of neurological disorders.
    Type: Application
    Filed: July 5, 2012
    Publication date: May 15, 2014
    Applicant: SYKEHUSET SØRLANDET HF
    Inventors: Christian Kersten, Marte Grønlie Cameron, Svein Mjåland
  • Transducer arrangement
    Patent number: 5877996
    Abstract: Transducer arrangement for use as receivers in acoustic borehole measurements, in particular for the purpose of geological steering, stratigraphic imaging and control during drilling of deviated and horizontal wells, whereby transducer sensitivity is focused generally in radial directions normal to the drill string axis in close proximity to the drill bit (45). Two separate and substantially similar transducer elements are adapted to be located at substantially the same axial position along the drill string axis. The transducer elements having their output terminals interconnected with opposite polarities, so as to have a combined minimum response to incident acoustic waves and vibrations being identical at both transducer elements.
    Type: Grant
    Filed: July 15, 1996
    Date of Patent: March 2, 1999
    Assignee: Den Norske Stats Oljeselskap A.S
    Inventors: Asbj.o slashed.rn Krokstad, Svein Mjaaland, Erik Iversen Nakken